Parkinson's Disease (PD) affects speech in the form of dysphonia and hypokinetic dysarthria. Multiple studies have evaluated PD's influence on different aspects of speech …
W Bouthour, P Mégevand, J Donoghue… - Nature Reviews …, 2019 - nature.com
Subthalamic deep brain stimulation (DBS) for Parkinson disease (PD) currently requires laborious open-loop programming, which can mitigate the benefits of this treatment …
RESUMO A doença de Parkinson é a segunda doença neurodegenerativa mais comum, tendo sido documentado um aumento significativo da sua prevalência nas últimas três …
In Parkinson's disease, the progressive neurodegeneration of nigrostriatal dopaminergic neurons in the substantia nigra pars compacta (SNc) is associated with classic motor …
The terms “on” and “off” were used by Marsden and his contemporaries over 40 years ago to describe times when Parkinson's disease patients experienced good motor function (“on”) …
E Lhommée, L Wojtecki, V Czernecki, K Witt… - The Lancet …, 2018 - thelancet.com
Background Although subthalamic stimulation is a recognised treatment for motor complications in Parkinson's disease, reports on behavioural outcomes are controversial …
MA Cenci, K Skovgård, P Odin - Neuropharmacology, 2022 - Elsevier
Dopamine replacement therapy with l-DOPA is the most efficacious symptomatic treatment for Parkinson's disease, but its utility is limited by a development of motor fluctuations and …
Background Non‐motor symptoms (NMS) are frequent in Parkinson's disease (PD). Objectives To estimate the prevalence of NMS and of non‐motor fluctuations (NMF) using …
Parkinson's disease is the second most common neurodegenerative disorder, and a significant increase in its prevalence in the past three decades has been documented …